Medicare Enrolled

Dr. Sameer Syed, M.D.

Pain Medicine · Plano, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
3151 W 15TH ST, Plano, TX 75075
2148174225
Registered in NPPES since 2010
NPI: 1083933089 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Syed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Syed? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Syed

Dr. Sameer Syed is a pain medicine specialist in Plano, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Syed performed 4,097 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Syed received a total of $16,666 from 42 pharmaceutical and/or device companies across 380 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Syed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years of NPI registration ▲ Top 17% volume in TX $16,666 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
4,097
Medicare services
Top 17% in TX for pain medicine
Not available
Unique patients (not deduplicated)
$120
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
1,120 $61 $187
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
1,098 $242 $741
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
629 $94 $310
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
467 $1 $50
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
177 $42 $241
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
84 $192 $2,558
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
84 $99 $1,283
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
69 $184 $1,884
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
60 $127 $450
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
51 $159 $3,750
Additional sacral spine nerve root injection with imaging
An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging.
49 $92 $1,930
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
45 $204 $2,848
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
42 $337 $6,000
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
39 $60 $188
Injection of anesthetic agent and/or steroid into other nerve or branch 29 $41 $625
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
27 $207 $4,500
Facet joint injection, second level, with imaging
An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement.
27 $107 $1,434
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,666
Total received (2018-2024)
Avg $2,381/year across 7 years
Top 15% in TX for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
380
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,913
2023
$1,134
2022
$590
2021
$1,000
2020
$821
2019
$1,786
2018
$7,422

Payments by company (2024)

Medtronic, Inc.
$1,918
BIOTRONIK NRO, Inc.
$608
Abbott Laboratories
$228
ABBVIE INC.
$224
Collegium Pharmaceutical, Inc.
$158
PFIZER INC.
$157
Nevro Corp.
$151
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$102
Curonix LLC
$98
SCILEX PHARMACEUTICALS INC.
$89
Nalu Medical, Inc.
$67
Azurity Pharmaceuticals, Inc.
$57
Fidia Pharma USA Inc.
$22
Bioventus LLC
$22
SPR Therapeutics, Inc
$12
Top 3 companies account for 70.4% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$7,136
Medtronic, Inc.
$2,025
Boston Scientific Corporation
$1,117
PFIZER INC.
$641
BIOTRONIK NRO, Inc.
$608
Nevro Corp.
$549
BOSTON SCIENTIFIC CORPORATION
$473
Collegium Pharmaceutical, Inc.
$387
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$385
Teva Pharmaceuticals USA, Inc.
$366
AbbVie Inc.
$286
ABBVIE INC.
$269
Biohaven Pharmaceuticals, Inc.
$264
Novartis Pharmaceuticals Corporation
$233
SCILEX PHARMACEUTICALS INC.
$183
Medtronic USA, Inc.
$164
Epimed International, Inc
$154
Scilex Pharmaceuticals Inc.
$146
Stimwave Technologies Incorporated
$135
Biohaven Pharmaceutical Holding Company Ltd.
$134
BioDelivery Sciences International, Inc.
$130
Vertos Medical, Inc.
$114
Curonix LLC
$98
Horizon Therapeutics plc
$86
Lilly USA, LLC
$85
Nalu Medical, Inc.
$67
Bioventus LLC
$61
Azurity Pharmaceuticals, Inc.
$57
Lundbeck LLC
$54
Amgen Inc.
$42
Horizon Pharma plc
$29
Integra LifeSciences Corporation
$27
Upsher-Smith Laboratories LLC
$23
Fidia Pharma USA Inc.
$22
Allergan, Inc.
$19
AstraZeneca Pharmaceuticals LP
$18
Assertio Therapeutics, Inc.
$16
Shionogi Inc
$14
Kowa Pharmaceuticals America, Inc.
$13
SPR Therapeutics, Inc
$12
Shire North American Group Inc
$12
Indivior Inc.
$12
Top 3 companies account for 61.7% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · Aimovig · BELBUCA · BOTOX · CODMAN CERTAS · COMIRNATY · DUEXIS · DUROLANE · Durolane · EMGALITY · ETERNA · Epidural needles and catheters · FLECTOR · GENERAL PAIN MANAGEMENT · General - Pain Management · HORIZANT · HYMOVIS · INTELLIS · INTELLIS ADAPTIVESTIM · LYRICA · MOVANTIK · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · OCTRODE · Octrode SCS Leads · PAXLOVID · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · Prospera · QULIPTA · RAYOS · RELISTOR · RELISTOR ORAL · SCS leads · SPECTRA WAVEWRITER · SPRINT PNS System · SUBLOCADE · SYNCHROMEDII · Seglentis · Senza · Swift-Lock SCS · Symproic · TOSYMRA SUMATRIPTAN NASAL SPRAY · UBRELVY · VECTRIS · VYEPTI · VYVANSE · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · XtampzaER · ZIPSOR · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pain medicine specialist in Plano?
Compare pain medicines in the Plano area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines in nearby ZIP areas
93
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY PLANO
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Syed is a clinical cardiology specialist, with above-average Medicare volume (top 17% in TX), with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Syed experienced with drug screening test?
Based on Medicare claims data, Dr. Syed performed 1,120 drug screening test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Syed receive payments from pharmaceutical companies?
Yes. Dr. Syed received a total of $16,666 from 42 companies across 380 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Syed's costs compare to other pain medicines in Plano?
Dr. Syed's average Medicare payment per service is $120. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Syed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →